Spyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYRE and other ETFs, options, and stocks.About SYRE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
SYRE Key Statistics
Stock Snapshot
The current Spyre Therapeutics(SYRE) stock price is $40.59, with a market capitalization of 3.19B. The stock trades at a price-to-earnings (P/E) ratio of -19.73.
As of 2026-03-05, Spyre Therapeutics(SYRE) stock has fluctuated between $39.90 and $41.50. The current price stands at $40.59, placing the stock +1.7% above today's low and -2.2% off the high.
Spyre Therapeutics(SYRE) shares are trading with a volume of 637.12K, against a daily average of 895.6K.
In the last year, Spyre Therapeutics(SYRE) shares hit a 52-week high of $45.76 and a 52-week low of $10.91.
In the last year, Spyre Therapeutics(SYRE) shares hit a 52-week high of $45.76 and a 52-week low of $10.91.
Analyst ratings
100%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.